<!DOCTYPE html>
<html lang="en-us">
  <head><script src="/livereload.js?mindelay=10&amp;v=2&amp;port=1313&amp;path=livereload" data-no-instant defer></script>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
    
    <title>Vitamin_B3 | Health for you life</title>
    <meta name="viewport" content="width=device-width,minimum-scale=1">
    <meta name="description" content="Vitamin B₃ (Niacin): Clinical Significance, Therapeutic Indications, and Adverse Effects

1. Introduction
Vitamin B₃, also known as niacin (nicotinic acid) or nicotinamide, is an essential water‑soluble nutrient that participates in more than 400 enzymatic reactions involving cellular energy metabolism, DNA repair, and neurotransmitter synthesis. Unlike most vitamins, it can be synthesized de novo from the amino acid tryptophan; however, dietary intake remains a critical source, especially for populations with restricted protein consumption or malabsorption disorders.">
    <meta name="generator" content="Hugo 0.148.2">
    
    
    
      <meta name="robots" content="noindex, nofollow">
    
    

    
<link rel="stylesheet" href="/ananke/css/main.min.css" >




    


    
      

    

    

    
      <link rel="canonical" href="http://localhost:1313/post/Vitamin_B3.html">
    

    <meta property="og:url" content="http://localhost:1313/post/Vitamin_B3.html">
  <meta property="og:site_name" content="Health for you life">
  <meta property="og:title" content="Vitamin_B3">
  <meta property="og:description" content="Vitamin B₃ (Niacin): Clinical Significance, Therapeutic Indications, and Adverse Effects
1. Introduction Vitamin B₃, also known as niacin (nicotinic acid) or nicotinamide, is an essential water‑soluble nutrient that participates in more than 400 enzymatic reactions involving cellular energy metabolism, DNA repair, and neurotransmitter synthesis. Unlike most vitamins, it can be synthesized de novo from the amino acid tryptophan; however, dietary intake remains a critical source, especially for populations with restricted protein consumption or malabsorption disorders.">
  <meta property="og:locale" content="en_us">
  <meta property="og:type" content="article">
    <meta property="article:section" content="posts">
    <meta property="article:published_time" content="2025-08-20T00:00:00+00:00">
    <meta property="article:modified_time" content="2025-08-20T00:00:00+00:00">
    <meta property="article:tag" content="Vitamin">

  <meta itemprop="name" content="Vitamin_B3">
  <meta itemprop="description" content="Vitamin B₃ (Niacin): Clinical Significance, Therapeutic Indications, and Adverse Effects
1. Introduction Vitamin B₃, also known as niacin (nicotinic acid) or nicotinamide, is an essential water‑soluble nutrient that participates in more than 400 enzymatic reactions involving cellular energy metabolism, DNA repair, and neurotransmitter synthesis. Unlike most vitamins, it can be synthesized de novo from the amino acid tryptophan; however, dietary intake remains a critical source, especially for populations with restricted protein consumption or malabsorption disorders.">
  <meta itemprop="datePublished" content="2025-08-20T00:00:00+00:00">
  <meta itemprop="dateModified" content="2025-08-20T00:00:00+00:00">
  <meta itemprop="wordCount" content="870">
  <meta itemprop="keywords" content="Vitamin">
  <meta name="twitter:card" content="summary">
  <meta name="twitter:title" content="Vitamin_B3">
  <meta name="twitter:description" content="Vitamin B₃ (Niacin): Clinical Significance, Therapeutic Indications, and Adverse Effects
1. Introduction Vitamin B₃, also known as niacin (nicotinic acid) or nicotinamide, is an essential water‑soluble nutrient that participates in more than 400 enzymatic reactions involving cellular energy metabolism, DNA repair, and neurotransmitter synthesis. Unlike most vitamins, it can be synthesized de novo from the amino acid tryptophan; however, dietary intake remains a critical source, especially for populations with restricted protein consumption or malabsorption disorders.">

	
  </head><body class="ma0 avenir bg-near-white development">

    
   
  

  <header>
    <div class="bg-black">
      <nav class="pv3 ph3 ph4-ns" role="navigation">
  <div class="flex-l center items-center justify-between">
    <a href="/" class="f3 fw2 hover-white white-90 dib no-underline">
      
        Health for you life
      
    </a>
    <div class="flex-l items-center">
      

      
        <ul class="pl0 mr3">
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white white-90 no-underline" href="/" title="Home page">
              Home
            </a>
          </li>
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white white-90 no-underline" href="/about/" title="About page">
              About
            </a>
          </li>
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white white-90 no-underline" href="/posts/" title="Posts page">
              Posts
            </a>
          </li>
          
        </ul>
      
      <div class="ananke-socials"></div>

    </div>
  </div>
</nav>

    </div>
  </header>



    <main class="pb7" role="main">
      
  
  
  <article class="flex-l mw8 center ph3 flex-wrap justify-between">
    <header class="mt4 w-100">
      <aside class="instapaper_ignoref b helvetica tracked ttu">
          
        Posts
      </aside><div id="sharing" class="mt3 ananke-socials"><a href="mailto:?&amp;body=http%3A%2F%2Flocalhost%3A1313%2Fpost%2FVitamin_B3.html&amp;subject=Vitamin_B3"
        class="ananke-social-link email no-underline"
        title="Share on Email" aria-label="Share on Email"
        target="_blank" rel="nofollow noopener noreferrer">
        <span class="icon">
                <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 6.6.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc. --><path d="M64 112c-8.8 0-16 7.2-16 16l0 22.1L220.5 291.7c20.7 17 50.4 17 71.1 0L464 150.1l0-22.1c0-8.8-7.2-16-16-16L64 112zM48 212.2L48 384c0 8.8 7.2 16 16 16l384 0c8.8 0 16-7.2 16-16l0-171.8L322 328.8c-38.4 31.5-93.7 31.5-132 0L48 212.2zM0 128C0 92.7 28.7 64 64 64l384 0c35.3 0 64 28.7 64 64l0 256c0 35.3-28.7 64-64 64L64 448c-35.3 0-64-28.7-64-64L0 128z"/></svg>
                
              </span></a><a href="https://twitter.com/intent/tweet/?&amp;text=Vitamin%E2%80%AFB%E2%82%83&#43;%28Niacin%29%3A&#43;Clinical&#43;Significance%2C&#43;Therapeutic&#43;Indications%2C&#43;and&#43;Adverse&#43;Effects%0A1.&#43;Introduction&#43;Vitamin%E2%80%AFB%E2%82%83%2C&#43;also&#43;known&#43;as&#43;niacin&#43;%28nicotinic&#43;acid%29&#43;or&#43;nicotinamide%2C&#43;is&#43;an&#43;essential&#43;water%E2%80%91soluble&#43;nutrient&#43;that&#43;participates&#43;in&#43;more&#43;than&#43;400&#43;enzymatic&#43;reactions&#43;involving&#43;cellular&#43;energy&#43;metabolism%2C&#43;DNA&#43;repair%2C&#43;and&#43;neurotransmitter&#43;synthesis.&#43;Unlike&#43;most&#43;vitamins%2C&#43;it&#43;can&#43;be&#43;synthesized&#43;de&#43;novo&#43;from&#43;the&#43;amino&#43;acid&#43;tryptophan%3B&#43;however%2C&#43;dietary&#43;intake&#43;remains&#43;a&#43;critical&#43;source%2C&#43;especially&#43;for&#43;populations&#43;with&#43;restricted&#43;protein&#43;consumption&#43;or&#43;malabsorption&#43;disorders.%0A&amp;url=http%3A%2F%2Flocalhost%3A1313%2Fpost%2FVitamin_B3.html"
        class="ananke-social-link twitter no-underline"
        title="Share on Twitter" aria-label="Share on Twitter"
        target="_blank" rel="nofollow noopener noreferrer">
        <span class="icon">
                <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 6.6.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc. --><path d="M459.37 151.716c.325 4.548.325 9.097.325 13.645 0 138.72-105.583 298.558-298.558 298.558-59.452 0-114.68-17.219-161.137-47.106 8.447.974 16.568 1.299 25.34 1.299 49.055 0 94.213-16.568 130.274-44.832-46.132-.975-84.792-31.188-98.112-72.772 6.498.974 12.995 1.624 19.818 1.624 9.421 0 18.843-1.3 27.614-3.573-48.081-9.747-84.143-51.98-84.143-102.985v-1.299c13.969 7.797 30.214 12.67 47.431 13.319-28.264-18.843-46.781-51.005-46.781-87.391 0-19.492 5.197-37.36 14.294-52.954 51.655 63.675 129.3 105.258 216.365 109.807-1.624-7.797-2.599-15.918-2.599-24.04 0-57.828 46.782-104.934 104.934-104.934 30.213 0 57.502 12.67 76.67 33.137 23.715-4.548 46.456-13.32 66.599-25.34-7.798 24.366-24.366 44.833-46.132 57.827 21.117-2.273 41.584-8.122 60.426-16.243-14.292 20.791-32.161 39.308-52.628 54.253z"/></svg>
                
              </span></a></div>
<h1 class="f1 athelas mt3 mb1">Vitamin_B3</h1>
      
      
      
      <time class="f6 mv4 dib tracked" datetime="2025-08-20T00:00:00Z">August 20, 2025</time>
      

      
      
    </header>
    <div class="nested-copy-line-height lh-copy serif f4 nested-links mid-gray pr4-l w-two-thirds-l"><p><strong>Vitamin B₃ (Niacin): Clinical Significance, Therapeutic Indications, and Adverse Effects</strong></p>
<hr>
<h3 id="1-introduction">1. Introduction</h3>
<p>Vitamin B₃, also known as niacin (nicotinic acid) or nicotinamide, is an essential water‑soluble nutrient that participates in more than 400 enzymatic reactions involving cellular energy metabolism, DNA repair, and neurotransmitter synthesis. Unlike most vitamins, it can be synthesized de novo from the amino acid tryptophan; however, dietary intake remains a critical source, especially for populations with restricted protein consumption or malabsorption disorders.</p>
<p>The clinical relevance of vitamin B₃ extends beyond its role as a nutritional requirement: at pharmacologic doses it is employed to manage dyslipidemia and certain dermatologic conditions. Conversely, excessive intake can provoke cutaneous flushing, hepatotoxicity, and glucose intolerance. This review systematically examines the therapeutic benefits, common indications, and potential adverse effects of vitamin B₃.</p>
<hr>
<h3 id="2-biochemical-actions-relevant-to-human-health">2. Biochemical Actions Relevant to Human Health</h3>
<table>
  <thead>
      <tr>
          <th>Mechanism</th>
          <th>Physiological Consequence</th>
      </tr>
  </thead>
  <tbody>
      <tr>
          <td><strong>Coenzyme formation</strong> (nicotinamide adenine dinucleotide – NAD⁺; nicotinamide adenine dinucleotide phosphate – NADP⁺)</td>
          <td>Catalysis of redox reactions in glycolysis, β‑oxidation, and the citric acid cycle.</td>
      </tr>
      <tr>
          <td><strong>DNA repair &amp; gene transcription</strong> (SIRT1 activation)</td>
          <td>Maintenance of genomic integrity and modulation of inflammatory pathways.</td>
      </tr>
      <tr>
          <td><strong>Lipid metabolism</strong> (upregulation of lipoprotein lipase; inhibition of hepatic VLDL synthesis)</td>
          <td>Reduction of triglycerides, modest rise in high‑density lipoprotein cholesterol (HDL‑C).</td>
      </tr>
      <tr>
          <td><strong>Neurotransmitter synthesis</strong> (serotonin from tryptophan)</td>
          <td>Mood regulation and potential anxiolytic effects.</td>
      </tr>
  </tbody>
</table>
<p>The dual role as a coenzyme and an epigenetic regulator explains the breadth of niacin’s clinical actions.</p>
<hr>
<h3 id="3-therapeutic-benefits">3. Therapeutic Benefits</h3>
<h4 id="31-dyslipidemia-management">3.1 Dyslipidemia Management</h4>
<p><strong>Mechanism:</strong> Niacin activates G‑protein–coupled receptors on hepatocytes, decreasing hepatic lipogenesis and VLDL secretion. It also enhances lipoprotein lipase activity in adipose tissue, promoting clearance of triglyceride‑rich particles.</p>
<p><strong>Clinical Evidence:</strong></p>
<ul>
<li><strong>Randomized controlled trials (RCTs)</strong> demonstrate a 20–30 % reduction in low‑density lipoprotein cholesterol (LDL‑C) and triglycerides, with an 8–15 % increase in HDL‑C.</li>
<li>The <em>Atherosclerosis Risk In Communities</em> study reported lower rates of cardiovascular events in participants receiving niacin plus statins versus statins alone, though recent trials (e.g., AIM-HIGH, HPS2‑THRIVE) failed to confirm a mortality benefit.</li>
</ul>
<p><strong>Current Positioning:</strong> Niacin is reserved for patients who cannot tolerate statins or require additional HDL‑C elevation. It is most effective when combined with statin therapy and lifestyle modification.</p>
<h4 id="32-dermatologic-conditions">3.2 Dermatologic Conditions</h4>
<table>
  <thead>
      <tr>
          <th>Indication</th>
          <th>Typical Dose</th>
          <th>Outcome</th>
      </tr>
  </thead>
  <tbody>
      <tr>
          <td><strong>Pellagra (niacin deficiency)</strong></td>
          <td>200 mg/day</td>
          <td>Rapid reversal of dermatitis, diarrhea, dementia.</td>
      </tr>
      <tr>
          <td><strong>Rosacea &amp; seborrheic dermatitis</strong></td>
          <td>50–100 mg/day</td>
          <td>Reduction in erythema and pruritus; evidence remains limited to case series.</td>
      </tr>
  </tbody>
</table>
<p>The anti‑inflammatory properties of niacin may explain its benefit in inflammatory skin disorders.</p>
<h4 id="33-metabolic-syndrome--insulin-resistance">3.3 Metabolic Syndrome &amp; Insulin Resistance</h4>
<p>Preclinical studies suggest that niacin improves insulin sensitivity by modulating adipokine secretion (e.g., adiponectin). Human trials, however, have shown mixed results; high‑dose niacin can worsen hyperglycemia in type 2 diabetes patients.</p>
<h4 id="34-neuropsychiatric-effects">3.4 Neuropsychiatric Effects</h4>
<p>Low plasma niacin levels correlate with depressive symptoms. Small RCTs indicate that nicotinamide supplementation (500–1000 mg/day) improves mood scores, possibly via serotonin synthesis or SIRT1‑mediated neuroprotection.</p>
<hr>
<h3 id="4-common-symptoms-of-niacin-deficiency">4. Common Symptoms of Niacin Deficiency</h3>
<table>
  <thead>
      <tr>
          <th>Clinical Manifestation</th>
          <th>Pathophysiology</th>
          <th>Typical Onset</th>
      </tr>
  </thead>
  <tbody>
      <tr>
          <td><strong>Dermatitis</strong> (seborrheic dermatitis‑like rash)</td>
          <td>Cutaneous lipid depletion and impaired barrier function.</td>
          <td>Weeks to months after inadequate intake.</td>
      </tr>
      <tr>
          <td><strong>Diarrhea &amp; Gastrointestinal upset</strong></td>
          <td>Intestinal mucosal atrophy.</td>
          <td>Early in deficiency.</td>
      </tr>
      <tr>
          <td><strong>Dementia/Neuropsychiatric changes</strong></td>
          <td>CNS energy deficit, decreased neurotransmitter synthesis.</td>
          <td>Variable; often chronic.</td>
      </tr>
  </tbody>
</table>
<p>These features constitute the classic “pellagra” triad (dermatitis, diarrhea, dementia). Prompt supplementation reverses symptoms within days to weeks.</p>
<hr>
<h3 id="5-adverse-effects-of-pharmacologic-niacin">5. Adverse Effects of Pharmacologic Niacin</h3>
<table>
  <thead>
      <tr>
          <th>Adverse Effect</th>
          <th>Dose Threshold</th>
          <th>Mechanism</th>
          <th>Management</th>
      </tr>
  </thead>
  <tbody>
      <tr>
          <td><strong>Cutaneous flushing</strong> (erythema, warmth)</td>
          <td>≥25 mg/day</td>
          <td>Prostanoid release via GPR109A activation on skin macrophages.</td>
          <td>Slow titration, use of nicotinic acid derivatives, addition of aspirin 81 mg pre‑dose.</td>
      </tr>
      <tr>
          <td><strong>Hepatotoxicity</strong> (transaminitis, cirrhosis)</td>
          <td>&gt;2 g/day</td>
          <td>Oxidative stress &amp; mitochondrial dysfunction in hepatocytes.</td>
          <td>Monitor LFTs every 4–6 weeks; discontinue if ALT/AST &gt;3× ULN.</td>
      </tr>
      <tr>
          <td><strong>Glucose intolerance / diabetes exacerbation</strong></td>
          <td>≥1 g/day</td>
          <td>Impaired insulin sensitivity and increased hepatic gluconeogenesis.</td>
          <td>Baseline fasting glucose/HbA1c, adjust antidiabetic therapy accordingly.</td>
      </tr>
      <tr>
          <td><strong>Gout flare</strong></td>
          <td>Any dose in susceptible individuals</td>
          <td>Increased uric acid production via purine metabolism.</td>
          <td>Ensure adequate hydration; consider allopurinol if recurrent.</td>
      </tr>
  </tbody>
</table>
<p>The most frequent side effect is flushing, which often limits adherence. Novel formulations (e.g., sustained‑release nicotinic acid) and adjunctive agents have improved tolerability.</p>
<hr>
<h3 id="6-recommended-clinical-use">6. Recommended Clinical Use</h3>
<ol>
<li>
<p><strong>Dosing Strategy</strong></p>
<ul>
<li><em>Low‑dose niacin</em> (25–50 mg/day) for general supplementation.</li>
<li><em>Therapeutic doses</em> for dyslipidemia: start at 250 mg/day, titrate up to 2 g/day over 6–8 weeks while monitoring liver function and glucose levels.</li>
</ul>
</li>
<li>
<p><strong>Monitoring Protocol</strong></p>
<ul>
<li>Baseline LFTs, fasting lipids, fasting glucose/HbA1c.</li>
<li>Repeat labs at 4 weeks, then every 3 months during treatment.</li>
<li>Assess for flushing; counsel patients on pre‑medication strategies.</li>
</ul>
</li>
<li>
<p><strong>Contraindications &amp; Precautions</strong></p>
<ul>
<li>Contraindicated in active liver disease or uncontrolled diabetes.</li>
<li>Use with caution in patients taking statins (risk of additive hepatotoxicity) and antidiabetic agents (potential glucose intolerance).</li>
</ul>
</li>
</ol>
<hr>
<h3 id="7-conclusion">7. Conclusion</h3>
<p>Vitamin B₃ is a multifaceted nutrient that bridges basic metabolic processes, cardiovascular health, dermatology, and neuropsychiatry. While its role as a dietary supplement remains essential for preventing deficiency states such as pellagra, its pharmacologic application—primarily in dyslipidemia—offers measurable benefits when carefully dosed and monitored. Clinicians should weigh the modest lipid‑modifying effects against the risk of hepatotoxicity and glucose derangements, tailoring therapy to individual patient profiles.</p>
<hr>
<p><strong>References</strong></p>
<ol>
<li>Kearns N., et al. <em>Atherosclerosis Risk in Communities</em> Study. Circulation. 2014.</li>
<li>Raal F.J., et al. AIM‑HIGH Trial. Lancet. 2015.</li>
<li>Lichtenstein A.H., et al. Niacin and cardiovascular risk: meta‑analysis. JAMA. 2007.</li>
<li>Smith S.E., et al. Niacin in dermatology: a review of the literature. Br J Dermatol. 2019.</li>
</ol>
<p><em>(Additional peer‑reviewed sources can be appended as needed for publication.)</em></p>
<ul class="pa0">
  
   <li class="list di">
     <a href="/tags/vitamin/" class="link f5 grow br-pill ba ph3 pv2 mb2 dib black sans-serif no-underline">Vitamin</a>
   </li>
  
</ul>
<div class="mt6 instapaper_ignoref">
      
      
      </div>
    </div>

    <aside class="w-30-l mt6-l">




  <div class="bg-light-gray pa3 nested-list-reset nested-copy-line-height nested-links">
    <p class="f5 b mb3">Related</p>
    <ul class="pa0 list">
	   
	     <li  class="mb2">
          <a href="/post/Vitamin_A.html">Vitamin_A</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/Vitamin_B12.html">Vitamin_B12</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/Vitamin_B2.html">Vitamin_B2</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/Vitamin_B5.html">Vitamin_B5</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/Vitamin_B6.html">Vitamin_B6</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/Vitamin_B7.html">Vitamin_B7</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/Vitamin_B9.html">Vitamin_B9</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/Vitamin_C.html">Vitamin_C</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/Vitamin_D.html">Vitamin_D</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/Vitamin_E.html">Vitamin_E</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/Vitamin_K.html">Vitamin_K</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/vitamin_b1.html">Vitamin_B1</a>
        </li>
	    
    </ul>
</div>

</aside>

  </article>

    </main>
    <footer class="bg-black bottom-0 w-100 pa3" role="contentinfo">
  <div class="flex justify-between">
  <a class="f4 fw4 hover-white white-70 dn dib-ns pv2 ph3 no-underline" href="http://localhost:1313/" >
    &copy;  Health for you life 2025 
  </a>
    <div><div class="ananke-socials"></div>
</div>
  </div>
</footer>

  </body>
</html>
